IJE Advance Access originally published online on August 19, 2004
International Journal of Epidemiology 2004 33(5):936-944; doi:10.1093/ije/dyh278
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IJE vol.33 no.5 © International Epidemiological Association 2004; all rights reserved.
Review |
The emergence of epidemiology in the genomics age
1 Office of Genomics and Disease Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
2 Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, North Carolina, USA
3 Epidemiology Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland
Correspondence: Dr M Khoury. Office of Genomics and Disease Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E82, Atlanta, Georgia, USA 30333. E-mail: mkhoury@cdc.gov
| The first 150 words of the full text of this article appear below. |
As genomics and epidemiology begin to intersect, there is the potential for both fields to be altered in ways that are mutually beneficial (R Millikan1)
While observational epidemiology is considered to be the scientific foundation of public health2 it is often viewed as a soft science limited by an inherent inability to fully control for confounding, misclassification, and selection bias.3 Enter the genomics era.4,5 With the completion of the Human Genome Project, and the eventual identification of thousands of human genetic variants, scientists are predicting that the use of personalized genomic information will revolutionize the future practice of medicine6 and public health.7 In this paper, we discuss the emerging role of epidemiology in the genomics era. In particular, we show how synergistic interaction between genomics and epidemiology is not only mutually beneficial but crucial to the optimal development of each field in the 21st century. Our thesis is twofold:
. . . [Full Text of this Article]
| The impact of epidemiology on genomics |
|---|
Vision of genomics research in the 21st century
The need for a public health research strategy in genomics
The emergence of human genome epidemiology
Population-based gene discovery and characterization
Epidemiology and genomic tests
| The impact of genomics on epidemiology |
|---|
Emergence of large population cohort studies
Emergence of novel epidemiological study designs: the case-only method
Epidemiology and the problem of complexity
Emerging statistical approaches to complexity
Emergence of Mendelian randomization as a tool for epidemiological inference on environmental risk factors
| Concluding remarks |
|---|
This article has been cited by other articles:
![]() |
B. Lumbreras, M. Porta, and I. Hernandez-Aguado Assessing the social meaning, value and implications of research in genomics J. Epidemiol. Community Health, September 1, 2007; 61(9): 755 - 756. [Full Text] [PDF] |
||||
![]() |
M. J Khoury, J. Little, M. Gwinn, and J. P. Ioannidis On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies Int. J. Epidemiol., April 1, 2007; 36(2): 439 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J KHOURY and M. GWINN Genomics, epidemiology, and common complex diseases: let's not throw out the baby with the bathwater! Int. J. Epidemiol., October 1, 2006; 35(5): 1363 - 1364. [Full Text] [PDF] |
||||
![]() |
S. GALEA, R. ACIERNO, K. RUGGIERO, H. RESNICK, M. TRACY, and D. KILPATRICK Social Context and the Psychobiology of Posttraumatic Stress Ann. N.Y. Acad. Sci., July 1, 2006; 1071(1): 231 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V Buchanan, K. M Weiss, and S. M Fullerton Dissecting complex disease: the quest for the Philosopher's Stone? Int. J. Epidemiol., June 1, 2006; 35(3): 562 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Merikangas, N. C.P. Low, and J. Hardy Commentary: Understanding sources of complexity in chronic diseases--the importance of integration of genetics and epidemiology Int. J. Epidemiol., June 1, 2006; 35(3): 590 - 592. [Full Text] [PDF] |
||||
![]() |
G. D. Smith Randomised by (your) god: robust inference from an observational study design J. Epidemiol. Community Health, May 1, 2006; 60(5): 382 - 388. [Full Text] [PDF] |
||||
![]() |
D. Nitsch, M. Molokhia, L. Smeeth, B. L. DeStavola, J. C. Whittaker, and D. A. Leon Limits to Causal Inference based on Mendelian Randomization: A Comparison with Randomized Controlled Trials Am. J. Epidemiol., March 1, 2006; 163(5): 397 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Knoppers Of genomics and public health: Building public "goods"? Can. Med. Assoc. J., November 8, 2005; 173(10): 1185 - 1186. [Full Text] [PDF] |
||||
![]() |
M. B. Bracken Genomic Epidemiology of Complex Disease: The Need for an Electronic Evidence-based Approach to Research Synthesis Am. J. Epidemiol., August 15, 2005; 162(4): 297 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davey Smith Genetic epidemiology: an 'enlightened narrative'? Int. J. Epidemiol., October 1, 2004; 33(5): 923 - 924. [Full Text] [PDF] |
||||
![]() |
L. J Palmer The New Epidemiology: putting the pieces together in complex disease aetiology Int. J. Epidemiol., October 1, 2004; 33(5): 925 - 928. [Full Text] [PDF] |
||||




